Medicure (CVE:MPH) Stock Price Crosses Below 200 Day Moving Average – Time to Sell?

Medicure Inc. (CVE:MPH) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$1.01 and traded as low as C$0.98. Medicure shares last traded at C$0.98, with a volume of 1,506 shares changing hands.

Medicure Price Performance

The company has a current ratio of 1.87, a quick ratio of 1.29 and a debt-to-equity ratio of 2.06. The company has a 50 day moving average of C$0.93 and a 200-day moving average of C$1.01. The firm has a market capitalization of C$10.23 million, a P/E ratio of -3.92 and a beta of 0.90.

Medicure Company Profile

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.